3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential
These three spinoffs are already profitable.
Here's Why GE HealthCare Technologies Is a No-Brainer Growth Stock
The company has a significant margin expansion opportunity and many pathways to achieve it.
Wall Street Is Bullish on GE HealthCare as It Invests in AI
The stand-alone company that spun off from GE in January is off to a good start.
Could GE HealthCare Stock Help You Retire a Millionaire?
The healthcare specialist's fundamentals look sound, but it's the growth potential that is the big question mark for investors.
General Electric Is Getting Ready to Fire On all Cylinders
Management's recent guidance was better than many had expected it to be.
Why General Electric Stock Aced an 8% Gain Thursday
Don't be fooled. Even if GE hits its numbers this year, its stock costs too much.
2 Top Healthcare Stocks Defying the Bear Market
These two healthcare stocks have been swimming against the current.
Advantus Health Partners and GE HealthCare Announce Multi-Year Agreement to Expand Access to Healthcare Technology Management Services
Advantus Health Partners , a health care solutions company delivering more effective, efficient supply chain models to health care organizations, and GE HealthCare (Nasdaq: GEHC), one of the largest providers of medical equipment maintenance...
GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
GE HealthCare has today announced, at the European Congress of Radiology (ECR) in Vienna, Austria, the completion of Phase I subject recruitment in its early clinical development program for a first-of-its-kind manganese-based macrocyclic magnetic...
SonoThera™ Receives Exclusive Licensing of GE HealthCare’s Optison® and Sonazoid® Microbubble Products for use with its Ultrasound-guided Gene Therapy Platform
SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, today announced it has received exclusive, global, commercial licensing rights from GE HealthCare (Nasdaq:GEHC) for use of Optison...